Movement Alert｜Intuitive Surgical Intraday Rise 3.06% in Regular Trading, JPMorgan Raised Price Target to 475 USD

On October 22, Intuitive Surgical rose 3.06% in Regular Trading, trading at $440.5 per share, with turnover of $314 million.

The clearest catalyst for the move was a price-target increase by JPMorgan to $475, which helped improve sentiment after the prior session’s post-earnings selloff.

Earlier this week, Intuitive Surgical reported third-quarter adjusted EPS of $3.00 and revenue of $3.049 billion, both above market expectations. However, management tightened its procedure-growth outlook, saying global da Vinci procedure growth should trend closer to the midpoint of the 14% to 15% range, which had pressured the shares. Additional debate remains around US procedure softness, with RBC noting potential risks to 2027 procedure momentum from US pricing actions on instruments and accessories in the first half and China charge-code reductions starting in the fourth quarter. Even so, the latest target increase suggests some analysts still see support for the company’s medium-term fundamentals.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)